Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial
Public ClinicalTrials.gov record NCT00475085. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00475085
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Joseph Roscoe
- Other
- Enrollment
- 1,021 participants
Conditions and interventions
Conditions
Interventions
- aprepitant Drug
- dexamethasone Drug
- granisetron hydrochloride Drug
- palonosetron hydrochloride Drug
- prochlorperazine Drug
- placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2006
- Primary completion
- Nov 30, 2012
- Completion
- Not listed
- Last update posted
- Nov 9, 2015
Started 2006
United States locations
- U.S. sites
- 16
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| MBCCOP - Gulf Coast | Mobile | Alabama | 36695 | — |
| CCOP - Central Illinois | Decatur | Illinois | 62526 | — |
| CCOP - Wichita | Wichita | Kansas | 67214-3882 | — |
| CCOP - Grand Rapids | Grand Rapids | Michigan | 49503 | — |
| CCOP - Kalamazoo | Kalamazoo | Michigan | 49007-3731 | — |
| CCOP - Metro-Minnesota | Saint Louis Park | Minnesota | 55416 | — |
| CCOP - Kansas City | Kansas City | Missouri | 64131 | — |
| CCOP - Nevada Cancer Research Foundation | Las Vegas | Nevada | 89106 | — |
| CCOP - Hematology-Oncology Associates of Central New York | East Syracuse | New York | 13057 | — |
| CCOP - North Shore University Hospital | Manhassett | New York | 11030 | — |
| CCOP - Southeast Cancer Control Consortium | Goldsboro | North Carolina | 27534-9479 | — |
| CCOP - Columbus | Columbus | Ohio | 43215 | — |
| CCOP - Dayton | Dayton | Ohio | 45429 | — |
| CCOP - Greenville | Greenville | South Carolina | 29615 | — |
| CCOP - Northwest | Tacoma | Washington | 98405-0986 | — |
| CCOP - Marshfield Clinic Research Foundation | Marshfield | Wisconsin | 54449 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00475085, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2015 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00475085 live on ClinicalTrials.gov.